Abstract
Comorbid psychiatric disorders and drug use disorders (DUDs) are common among alcoholics (Regier, Farmer, Rae, Locke, Keith, Judd, & Goodwin, 1990; Kessler, McGonagle, Zhao, Nelson, Hughes, Eshleman, Wittchen, & Kendler, 1994). These comorbid disorders often predict a shorter time to relapse of alcoholism (Greenfield, Weiss, Muenz, Vagge, Kelly, Bello, & Michael, 1998). However, despite the prevalence and the adverse effects of this comorbidity, few controlled treatment studies have been conducted involving this dual diagnosis population (Litten & Allen, 1999). To date, most of these few studies of alcoholics with comorbid disorders have been restricted to studies of alcoholics with either comorbid major depression or comorbid anxiety disorders (Litten & Allen, 1995). The results of these trials suggest efficacy for SSRI antidepressants and tricyclic antidepressants for treating alcoholics with comorbid major depression and suggest efficacy for buspirone for treating alcoholics with comorbid anxiety disorders (Mason, Kocsis, Ritvo, & Cutler, 1996; Cornelius, Salloum, Ehler, Jarrett, Cornelius, Perel, Thase, & Black, 1997; Kranzler, Burleson, Del Boca, Babor, Korner, Brown, & Bohn, 1994). However, controlled treatment studies involving alcoholics with other comorbid disorders are almost totally lacking. Consequently, to date, no empirically proven treatment exists for most of these comorbid disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anthony, J.C., Warner, L.A., & Kessler, R.C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, and controlled substances and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2, 244–268.
Batki, S.L., Manfredi, L.B., Jacob, P., & Jones, R.T. (1993). Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine benzoylecgonine concentrations. Journal of Clinical Psychopharmacology 13, 243–250.
Bowden, C.L., Brugger, A.M., Suann, A.C., Calabrese, J.R., Janicak, P.G., Petty, F, Dilsaver, S.C., Davis, J.M., Rush, A.J., Smally, J.G., Garza-Trevino, E.S., Risch, C, Goodnick, P.J., & Morris, D.D. (1994). Efficacy of divalproex vs. lithium and placebo in the treatment of mania. Journal of the American Medical Association 271, 918–924.
Brady, K.T., Halligan, P., & Malcolm, R.J. (1999). Dual diagnosis. In M. Galanter & H.D. Kleber (eds.), Textbook of Substance Abuse Treatment, 2nd ed., Washington, DC: The American Psychiatric Press, pp. 475–483.
Brady, K.T., Sonne, S.C., Anton, R., & Ballenger, J.C. (1995). Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study. Journal of Clinical Psychiatry 56, 118–121.
Bruno, F. (1989). Buspirone treatment of alcoholic patients. Psychopathology 22, 49–59.
Bukstein, O.G., Glancy, L.J., & Kaminer, Y. (1989). Comorbidity of substance abuse and other psychiatric disorders in adolescents. American Journal of Psychiatry 146, 1131–1141.
Clark, D.B., Parker, A.M., & Lynch, K.G. (1999). Psychopathology and substance-related problems during early adolescence: A survival analysis. Journal of Clinical Child Psychology 28, 333–341.
Clark, D.B., Pollock, N.K., Bukstein, O.G., Mezzich, A.C., Bromberger, J.T., & Donovan, J.E. (1997). Gender and comorbid psychopathology in adolescents with alcohol dependence. Journal of the American Academy of Child and Adolescent Psychiatry 36, 1195–1203.
Cornelius, J.R., Bukstein, O.G., Birmaher, B., Salloum, I.M., Lynch, K., Pollock, N.K., Gershon, S., & Clark, D.B. (2001). Fluoxetine in adolescents with major depression and an alcohol use disorder: An open label trial. Addictive Behaviors 26, 735–739.
Cornelius, J.R., Fabrega, H., Cornelius, M.D., Mezzich J.E., Maher P.J., Salloum, I.M., Thase, M.E., & Ulrich, R.F. (1996). Racial effects on the clinical presentation of alcoholics at a psychiatric hospital. Comprehensive Psychiatry 37, 102–108.
Cornelius, J.R., Jarrett, P.J., Thase, M.E., Fabrega, H., Haas, G.L., Jones-Barlock, J., Mezzich, J.E., & Ulrich, R.F. (1995). Gender effects on the clinical presentation of alcoholics at a psychiatric hospital. Comprehensive Psychiatry 36, 1–7.
Cornelius, J.R., Perkins, K.A., Salloum, I.M., Thase, M.E., & Moss, H.B. (1999). Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients. Journal of Clinical Psychopharmacology 19, 183–184.
Cornelius, J.R., Pringle, J., Jernigan J., Kirisci, L., & Clark, D.B. (2001). Correlates of mental health service utilization and unmet need among a sample of male adolescents. Addictive Behaviors 26, 11–19.
Cornelius, J.R., Salloum, I.M., Cornelius, M.D., Perel, J.M., Thase, M.E., Ehler, J.G., & Mann, J.J. (1993). Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacology Bulletin 29, 195–199.
Cornelius, J.R., Salloum, I.M., Mezzich, J.E., Cornelius, M.D., Fabrega, H., Ehler, J.G., Ulrich, R.F., Thase, M.E., & Mann, J.J. (1995). Disproportionate suicidality in patients with comorbid major depression and alcoholism. American Journal of Psychiatry 152, 358–364.
Cornelius, J.R., Salloum I.M., Day, N.L., Thase, M.E., & Mann, J.J. (1996). Patterns of suicidality and alcohol use in alcoholics with major depression. Alcoholism: Clinical and Experimental Research 20, 1451–1455.
Cornelius, J.R., Salloum, I.M., Ehler, J.G., Jarrett, P.J., Cornelius, M.D., Perel, J.M., Thase, M.E., & Black, A. (1997). Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Archives of General Psychiatry 54, 700–705.
Cornelius, J.R., Salloum, I.M., Thase, M.E., Haskett, R.F., Daley, D.C., Jones-Barlock, A., Upsher, C, & Perel, J.M. (1998). Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacology Bulletin 34, 117–121.
Cornelius, J.R., Salloum, I.M., Haskett, R.F., Ehler, J.G., Jarrett, P.J., Thase, M.E., & Perel, J.M. (1999). Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addictive Behaviors 24, 111–114.
Cornelius, J.R., Salloum, I.M., Haskett, R.F., Daley, D.C., Cornelius, M.D., Thase, M.E., & Perel, J.M. (2000). Fluoxetine versus placebo in depressed alcoholics: A one-year follow-up study. Addictive Behaviors 25, 307–310.
Cornelius, J.R., Salloum, I.M., Lynch, K., Clark, D.B., & Mann, J.J. (2001). Treating the substance-abusing suicidal patient. In H. Hendin & J.J. Mann (eds.), The Annals of the New York Academy of Sciences, 932, 78–93.
Cornelius, J.R., Thase, M.E., Salloum, I.M., Cornelius, M.D., Black, A., & Mann, J.J. (1998). Cocaine use associated with increased suicidal behavior in depressed alcoholics. Addictive Behaviors 23, 119–121.
Dorus, W., Ostrow, D.G., Anton, R., Cushman, P., Collins, J.F., Schaefer, V., Charles, H.L., Desai, P., Hayashida, M., Malkerneker, U., Willenbring, M., Fiscella, R., & Sather, M.R. (1989). Lithium treatment of depressed and nondepressed alcoholics. Journal of the American Medical Association 262, 1646–1652.
Emslie, G.J., Rush, A.J., Weinberg, W.A., Kowatch, R.A., Hughes, C.W., Carmody, T., & Rintelmann, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 54, 1031–1037.
Fawcett, J., Clark, D.L., Aagesen, C.A., Pinasi, V.D., Tilkin, J.M., Sellers, D., McGuire, M., & Gibbons, R.D. (1987). A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Archives of General Psychiatry 44, 248–256.
George, D.T., Rawlings, R., Eckardt, M.J., Phillips, M.J., Shoaf, S.E., & Linnoila, M. (1999). Buspirone treatment of alcoholism: Age of onset and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcoholism: Clinical and Experimental Research 23, 272–278.
Greenfield, S.F., Weiss, R.D., Muenz, L.R., Vagge, L.M., Kelly, J.F., Bello, L.R., & Michael, J. (1998). The effect of depression on return to drinking. Archives of General Psychiatry 55, 259–265.
Helzer, J.E., & Pryzbeck, T.R. (1998). The co-occurrence of alcoholism and other psychiatric disorders in the general population and its impact on treatment. Journal of Studies on Alcohol 49, 219–244.
Kessler, R.C., Crum, R.M., Warner, L.A., Nelson, C.B., Schulenberg, J., & Anthony, J.C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 54, 313–321.
Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.U., & Kendler, K.S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8–19.
King, C.A., Naylor, M.W., Hill, E.M., Shain, B.N., & Greden, J.F. (1993). Dysthymia characteristic of heavy alcohol use in depressed adolescents. Biological Psychiatry 33, 210–212.
Kranzler, H.R., Burleson, J.A., Del Boca, F.K., Babor, T.F., Korner, P., Brown, J., & Bohn, M. (1994). Buspirone treatment of anxious alcoholics. Archives of General Psychiatry 51, 720–731.
Kranzler, H.R., Burleson, J.A., Korner, P., Del Boca, F.K., Bohn, M.J., Brown, J., & Liebowitz, N. (1995). Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry 152, 391–397.
Litten, R.Z., & Allen, J.P. (1995). Pharmacotherapy for alcoholics with collateral depression or anxiety: An update of research findings. Experimental and Clinical Psychopharmacology 3, 87–93.
Litten, R.Z., & Allen, J.P. (1998). Pharmacologic treatment of alcoholics with collateral depression: Issues and future directions. Psychopharmacology Bulletin 34, 107–110.
Litten, R.Z., & Allen, J.P. (1999). Medications for alcohol, illicit drug, and tobacco dependence: An update of research findings. Journal of Substance Abuse Treatment 16, 105–112.
Litten, R.Z., & Fertig, J. (1996). International update: New findings on promising medications. Alcoholism: Clinical and Experimental Research 20(Suppl), 216A–218A.
Malcolm, R., Anton, R.F., Randall, C.L., Johnston, A., Brady, K., & Thevos, A. (1992). A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism: Clinical and Experimental Research 16, 1007–1013.
Malec, E., Malec, T., Gagne, M.A., & Dongier, M. (1996). Buspirone in the treatment of alcohol dependence: A placebo-controlled trial. Alcoholism: Clinical and Experimental Research 20, 307–312.
Martin, C.S., Kaczynski, N.A., Maisto, S.A., Bukstein, O.G., & Moss, H.B. (1995). Patterns of DSM-IV alcohol abuse and dependence symptoms in adolescent drinkers. Journal of Studies on Alcohol 56, 672–680.
Mason, B.J., Kocsis, J.H., Ritvo, C.E., & Cutler, R.B. (1996). A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. Journal of the American Medical Association 275, 761–767.
McGrath, P.J., Nunes, E.V., Stewart, J.W., Goldman, D., Agosti, V., Ocepek-Welikson, K., & Quitkin, P.M. (1996). Imipramine treatment of alcoholics with major depression: A placebo-controlled clinical trial. Archives of General Psychiatry 53, 232–240.
McLellan, A.T., Luborsky, L., Woody, G.E., O’Brien, C.P., & Druley, K.A. (1983). Predicting response to alcohol and drug abuse treatments. Archives of General Psychiatry 40, 620–625.
Naranjo, C.A., Kadlec, K.E., Sanhueza, P., Woodley-Remus, D., & Sellers, E.M. (1990). Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clinical Pharmacology and Therapeutics 47, 490–498.
Nunes, E.V., McGrath, P.F., Quitkin, F.M., Stewart, J.W., Goehl, L., & Ocepek-Welikson, K. (1996). Predictors of antidepressant response in depressed alcoholic patients. American Journal of Addiction 5, 308–312.
O’Malley, S.S., & Carroll, K.M. (1996). Psychotherapeutic considerations in pharmacological trials. Alcoholism: Clinical and Experimental Research 20, 17A–22A.
Paille, F.M., Guelfi, J.D., Perkins, A.C., Royer, R.J., Steru, L., & Parot, P. (1995). Double-blind randomized multicenter trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcoholism 30, 239–247.
Powell, B.J., Campbell, J.L., Landon, J.F., Liskou, B.I., Thomas, H.M., Nickel, E.J., Dale, T.M., Penick, E.C., Samuelson, S.D., & Lacoursiere, R.B. (1995). A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. Alcoholism: Clinical and Experimental Research 19, 462–468.
Project MATCH Research Group. (1998). Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research 22, 1300–1311.
Regier, D.A., Farmer, M.E., Rae, D.E., Locke, B.Z., Keith, E.J., Judd, L.L., & Goodwin, F.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association 264, 2511–2518.
Riggs, P.D., Mikulich, S.K., Coffman, L.M., & Crowley, T.J. (1997). Fluoxetine in drug-dependent delinquents with major depression: An open trial. Journal of Child and Adolescent Psychopharmacology 7, 87–95.
Roy A. (1998). Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biological Psychiatry 44, 633–637.
Salloum, I.M., Cornelius, J.R., Thase, M.E., Daley, D.C., Kirisci, L., & Spotts, C. (1998). Naltrexone utility in depressed alcoholics. Psychopharmacology Bulletin 34, 111–115.
Salloum, I.M., Cornelius, J.R., Mezzich, J.E., Kirisci, L., Daley, D.C., Spotts, C.R., & Zuckoff, A. (2001). Characterizing female bipolar alcoholic patients presenting for initial evaluation. Addictive Behaviors 26, 341–348.
Tollefson, G.D., Montague-Clouse, J., & Tollefson, S.L. (1992). Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). Journal of Clinical Psychopharmacology 12, 19–26.
Vitiello, B., & Jensen, P.S. (1997). Medication development and testing in children and adolescents. Archives of General Psychiatry 54, 871–876.
Volpicelli, J.R., Alterman, A.I., Hayashida, M., & O’Brien, C.P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49, 876–880.
Wilkins, J.N. (1997). Pharmacotherapy of schizophrenia patients with comorbid substance abuse. Schizophrenia Bulletin 23, 215–228.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Cornelius, J.R., Bukstein, O., Salloum, I., Clark, D. (2002). Alcohol and Psychiatric Comorbidity. In: Galanter, M., et al. Recent Developments in Alcoholism. Recent Developments in Alcoholism, vol 16. Springer, Boston, MA. https://doi.org/10.1007/0-306-47939-7_24
Download citation
DOI: https://doi.org/10.1007/0-306-47939-7_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47258-9
Online ISBN: 978-0-306-47939-7
eBook Packages: Springer Book Archive